Article
BMPR1B up-regulation via a miRNA binding site variation defines endometriosis susceptibility and CA125 levels.
PloS one - 1 Jan 2013
Chang Cherry Yin-Yi, Chen Yi, Lai Ming-Tsung, Chang Hui-Wen, Cheng Jack, Chan Carmen, Chen Chih-Mei, Lee Shan-Chih, Lin Ying-Ju, Wan Lei, Tsai Pei-Wen, Yang Su-Han, Chung Ching, Sheu Jim Jinn-Chyuan, Tsai Fuu-Jen
Abstract excerpt
BACKGROUND: Bone morphogenetic protein receptor I B (BMPR1B) is a transmembrane receptor mediating TGF-β signal transduction. Recent studies indicate a tumor suppressor role for BMPR1B in ovarian cancer. Polymorphism at BMPR1B 3'UTR within the miR-125b binding site alters its binding affinity toward the miRNA, which may result in insufficient post-transcriptional repression. METHODS: Single-nucleotide...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
